This study sought to identify barriers to accessing care during the COVID-19 pandemic for patients with opioid use disorder in the United States. The qualitative research was conducted via double-blinded, 30-minute phone interviews with providers and payers. Findings identified strategies adopted by health care organizations to overcome access barriers to care and medications for OUD.